KCNA3 and inflammation: HsTX1[R14A] is a potent Kv1.3 channel blocker with excellent selectivity over other potassium channels, and is therefore a potential therapeutic for the treatment of a variety of immune-related diseases associated with chronic inflammation, including systemic or organ-specific autoimmune diseases13.